NATIONAL INSTITUTES OF HEALTH
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia
- Conditions
- Inflammatory Breast Cancer
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 250
- Registration Number
- NCT00344071
- Locations
- 🇹🇳
Charles Nicolle Hospital, Tunisia, Tunis, Tunisia
🇪🇬Cairo University Hospital, Cairo, Egypt
🇪🇬National Cancer Institute-Cairo, Cairo, Egypt
Gene Expression and Inflammation in Overweight Subjects
- Conditions
- Nutrition TherapyInflammationObesity
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2019-12-17
- Target Recruit Count
- 144
- Registration Number
- NCT00344266
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province
- Conditions
- Precancerous Gastric Lesions
- Interventions
- Drug: Amoxicillin/omeprazole
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 3411
- Registration Number
- NCT00339768
- Locations
- 🇨🇳
Beijing Institute for Cancer Research, Beijing, China
Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States
- Conditions
- Renal Cell CarcinomaKidney Cancer
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 2424
- Registration Number
- NCT00340457
- Locations
- 🇺🇸
Wayne State University, Detroit, Michigan, United States
🇺🇸University of Illinois at Chicago, Chicago, Illinois, United States
Continuation of Follow-up of DES-Exposed Cohorts
- Conditions
- Autoimmune DiseaseProstate CancerOvarian CancerEndometrial CancerBreast Cancer
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2020-11-16
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 10805
- Registration Number
- NCT00340600
- Locations
- 🇺🇸
Boston University School of Public Health, Boston, Massachusetts, United States
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
- Conditions
- Lung Neoplasms
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2020-05-11
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 5625
- Registration Number
- NCT00339859
- Locations
- 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States
🇺🇸VA Hospital, Baltimore, Baltimore, Maryland, United States
Interdisciplinary Case-Control Study of Bladder Cancer in Spain
- Conditions
- Bladder Cancer
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 2925
- Registration Number
- NCT00341861
- Locations
- 🇪🇸
Institut Municipal d'Investigacio Medica, Barcelona, Spain
Fat Cell Size in Insulin Resistance
- Conditions
- Obesity
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2020-08-17
- Target Recruit Count
- 782
- Registration Number
- NCT00341406
- Locations
- 🇺🇸
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), 9000, Bethesda, Maryland, United States
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
- Conditions
- Postmenopausal BleedingVaginal BleedingEndometrial CancerEndometrial Hyperplasia
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 745
- Registration Number
- NCT00339651
- Locations
- 🇺🇸
Kaiser Permanente Northwest, Hillsboro, Oregon, United States
HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)
- Conditions
- HIV
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 3500
- Registration Number
- NCT00339430
- Locations
- 🇺🇸
National Cancer Institute (NCI), 9000 Rockville Pike, Bethesda, Maryland, United States